Skip to content

13F-HR filed by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-12, with 44 holding rows worth $198,193,000.

Accession
0001398344-19-019529
Filed
2019-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 45 entries on the cover page, a total value of $198,193,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $198,194,000 with VALUE read as thousands by filing date, 13F file number 028-15679. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Boston Scientific Corporation101137107COM200,000$8,138,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock50,000$7,438,000thousands by filing date
HUMANA INC COM444859102Stock29,000$7,414,000thousands by filing date
HCA Healthcare Inc40412C101COM60,000$7,225,000thousands by filing date
Merck & Co.,Inc.58933Y105COM85,000$7,155,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM40,000$6,777,000thousands by filing date
Abbott Laboratories002824100COM80,000$6,694,000thousands by filing date
BAXTER INTL INC071813109COM75,000$6,560,000thousands by filing date
Danaher Corporation235851102COM45,000$6,499,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR140,000$6,486,000thousands by filing date
Eli Lilly and Company532457108COM55,000$6,151,000thousands by filing date
BIO RAD LABS INC090572207CL A18,000$5,989,000thousands by filing date
GRIFOLS S A398438408SP ADR REP B NVT295,000$5,912,000thousands by filing date
ALCON AG ORD SHSH01301128Stock100,000$5,829,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock20,000$5,548,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock25,000$5,498,000thousands by filing date
UnitedHealth Group Inc91324P102COM25,000$5,433,000thousands by filing date
Stryker Corporation863667101COM25,000$5,408,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock50,000$5,352,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM20,000$5,183,000thousands by filing date
BECTON DICKINSON & CO075887109COM20,000$5,059,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW30,000$5,040,000thousands by filing date
CELGENE CORP151020104COM50,000$4,965,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock30,000$4,481,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM15,000$4,369,000thousands by filing date
Medtronic PlcG5960L103COM40,000$4,345,000thousands by filing date
INCYTE CORP COM45337C102Stock55,000$4,083,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock175,000$3,871,000thousands by filing date
ZOETIS INC CL A98978V103Stock30,000$3,738,000thousands by filing date
Elevance Health, Inc.036752103COM15,000$3,602,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR80,000$3,566,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM6,118$3,303,000thousands by filing date
HILL ROM HLDGS INC431475102COM30,000$3,157,000thousands by filing date
Cigna Corporation125523100COM20,000$3,036,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM45,000$3,033,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock40,000$1,730,000thousands by filing date
SEATTLE GENETICS INC812578102COM20,000$1,708,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM20,000$1,469,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM40,000$1,440,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM10,000$1,403,000thousands by filing date
TELADOC HEALTH INC87918A105COM19,100$1,293,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM15,000$1,130,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM45,296$918,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock10,000$766,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-19-019529this filing2019-11-12acceptance time not in the bulk data set